Gaspar J. Kitange

4.1k total citations
40 papers, 2.8k citations indexed

About

Gaspar J. Kitange is a scholar working on Genetics, Molecular Biology and Cancer Research. According to data from OpenAlex, Gaspar J. Kitange has authored 40 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Genetics, 24 papers in Molecular Biology and 16 papers in Cancer Research. Recurrent topics in Gaspar J. Kitange's work include Glioma Diagnosis and Treatment (25 papers), Brain Metastases and Treatment (7 papers) and DNA Repair Mechanisms (6 papers). Gaspar J. Kitange is often cited by papers focused on Glioma Diagnosis and Treatment (25 papers), Brain Metastases and Treatment (7 papers) and DNA Repair Mechanisms (6 papers). Gaspar J. Kitange collaborates with scholars based in United States, Japan and China. Gaspar J. Kitange's co-authors include Jann N. Sarkaria, C. David James, Brett L. Carlson, Mark A. Schroeder, Wenting Wu, Caterina Giannini, Paul A. Decker, Patrick T. Grogan, Robert B. Jenkins and Karla V. Ballman and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Gaspar J. Kitange

39 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gaspar J. Kitange United States 26 1.6k 1.4k 788 689 442 40 2.8k
Tatsuya Ozawa Japan 26 1.7k 1.1× 1.4k 0.9× 1.2k 1.5× 1.0k 1.5× 340 0.8× 49 3.5k
Benito Campos Germany 24 1.5k 1.0× 1.0k 0.7× 873 1.1× 1.0k 1.5× 253 0.6× 44 2.8k
Esther Hulleman Netherlands 28 2.3k 1.5× 1.1k 0.8× 875 1.1× 1.1k 1.6× 307 0.7× 81 3.7k
Fonnet E. Bleeker Netherlands 19 1.4k 0.9× 1.3k 0.9× 1.1k 1.4× 453 0.7× 435 1.0× 43 2.7k
S. Andrew United States 34 2.2k 1.4× 1.6k 1.1× 885 1.1× 741 1.1× 583 1.3× 84 4.2k
Anjan Misra United States 16 2.0k 1.3× 1.8k 1.3× 1.3k 1.7× 654 0.9× 352 0.8× 23 3.4k
Barbara Klink Germany 25 1.0k 0.7× 855 0.6× 775 1.0× 530 0.8× 370 0.8× 73 2.5k
Christiane B. Knobbe‐Thomsen Germany 30 2.2k 1.4× 1.1k 0.8× 909 1.2× 605 0.9× 388 0.9× 45 3.5k
Olga A. Guryanova United States 17 2.0k 1.2× 1.1k 0.8× 1.1k 1.3× 645 0.9× 258 0.6× 36 3.0k
Sameer Agnihotri Canada 29 1.9k 1.2× 1.0k 0.7× 1.3k 1.6× 443 0.6× 271 0.6× 74 3.2k

Countries citing papers authored by Gaspar J. Kitange

Since Specialization
Citations

This map shows the geographic impact of Gaspar J. Kitange's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gaspar J. Kitange with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gaspar J. Kitange more than expected).

Fields of papers citing papers by Gaspar J. Kitange

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gaspar J. Kitange. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gaspar J. Kitange. The network helps show where Gaspar J. Kitange may publish in the future.

Co-authorship network of co-authors of Gaspar J. Kitange

This figure shows the co-authorship network connecting the top 25 collaborators of Gaspar J. Kitange. A scholar is included among the top collaborators of Gaspar J. Kitange based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gaspar J. Kitange. Gaspar J. Kitange is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Yuanguo, Bing Bai, Wenming Bao, et al.. (2024). PKMζ, a Brain-specific PKCζ Isoform, is Required for Glycolysis and Myofibroblastic Activation of Hepatic Stellate Cells. Cellular and Molecular Gastroenterology and Hepatology. 19(3). 101429–101429.
2.
Chen, Jiajia, Shiv K. Gupta, Gaspar J. Kitange, et al.. (2020). Abstract 6506: Targeting ATM with AZD1390 for radio-sensitization of glioblastoma patient derived xenografts. Cancer Research. 80(16_Supplement). 6506–6506. 1 indexed citations
3.
Gupta, Shiv K., Emily J. Smith, Ann C. Mladek, et al.. (2019). PARP Inhibitors for Sensitization of Alkylation Chemotherapy in Glioblastoma: Impact of Blood-Brain Barrier and Molecular Heterogeneity. Frontiers in Oncology. 8. 670–670. 59 indexed citations
4.
Chen, Xiaoyue, Minjie Zhang, Haiyun Gan, et al.. (2018). A novel enhancer regulates MGMT expression and promotes temozolomide resistance in glioblastoma. Nature Communications. 9(1). 2949–2949. 198 indexed citations
5.
Kizilbash, Sani H., Shiv K. Gupta, Kenneth Tou En Chang, et al.. (2017). Restricted Delivery of Talazoparib Across the Blood–Brain Barrier Limits the Sensitizing Effects of PARP Inhibition on Temozolomide Therapy in Glioblastoma. Molecular Cancer Therapeutics. 16(12). 2735–2746. 60 indexed citations
6.
Nagel, Zachary D., Gaspar J. Kitange, Shiv K. Gupta, et al.. (2016). DNA Repair Capacity in Multiple Pathways Predicts Chemoresistance in Glioblastoma Multiforme. Cancer Research. 77(1). 198–206. 102 indexed citations
7.
Kitange, Gaspar J., Ann C. Mladek, Mark A. Schroeder, et al.. (2016). Retinoblastoma Binding Protein 4 Modulates Temozolomide Sensitivity in Glioblastoma by Regulating DNA Repair Proteins. Cell Reports. 14(11). 2587–2598. 53 indexed citations
8.
Gupta, Shiv K., Sani H. Kizilbash, Brett L. Carlson, et al.. (2015). Delineation ofMGMTHypermethylation as a Biomarker for Veliparib-Mediated Temozolomide-Sensitizing Therapy of Glioblastoma. JNCI Journal of the National Cancer Institute. 108(5). djv369–djv369. 93 indexed citations
9.
Kitange, Gaspar J., Ann C. Mladek, Brett L. Carlson, et al.. (2012). Inhibition of Histone Deacetylation Potentiates the Evolution of Acquired Temozolomide Resistance Linked to MGMT Upregulation in Glioblastoma Xenografts. Clinical Cancer Research. 18(15). 4070–4079. 125 indexed citations
10.
Pavlyukov, Marat S., Kaushal Joshi, Habibe Kurt, et al.. (2012). Impairment of Glioma Stem Cell Survival and Growth by a Novel Inhibitor for Survivin–Ran Protein Complex. Clinical Cancer Research. 19(3). 631–642. 79 indexed citations
11.
Youland, Ryan S., Gaspar J. Kitange, Timothy E. Peterson, et al.. (2012). The role of LAT1 in 18F-DOPA uptake in malignant gliomas. Journal of Neuro-Oncology. 111(1). 11–18. 109 indexed citations
12.
Kitange, Gaspar J., Brett L. Carlson, Mark A. Schroeder, et al.. (2010). Expression of CD74 in high grade gliomas: a potential role in temozolomide resistance. Journal of Neuro-Oncology. 100(2). 177–186. 43 indexed citations
13.
Kitange, Gaspar J., Thomas M. Kollmeyer, Mark E. Law, et al.. (2009). Characterization and gene expression profiling in glioma cell lines with deletion of chromosome 19 before and after microcell‐mediated restoration of normal human chromosome 19. Genes Chromosomes and Cancer. 48(10). 854–864. 7 indexed citations
14.
Sarkaria, Jann N., Gaspar J. Kitange, C. David James, et al.. (2008). Mechanisms of Chemoresistance to Alkylating Agents in Malignant Glioma. Clinical Cancer Research. 14(10). 2900–2908. 291 indexed citations
15.
Kitange, Gaspar J., Brett L. Carlson, Ann C. Mladek, et al.. (2008). Evaluation of MGMT promoter methylation status and correlation with temozolomide response in orthotopic glioblastoma xenograft model. Journal of Neuro-Oncology. 92(1). 23–31. 74 indexed citations
16.
Kitange, Gaspar J., Brett L. Carlson, Mark A. Schroeder, et al.. (2008). Induction of MGMT expression is associated with temozolomide resistance in glioblastoma xenografts. Neuro-Oncology. 11(3). 281–291. 297 indexed citations
17.
Kitange, Gaspar J., et al.. (2003). Recent advances in the molecular genetics of primary gliomas. Current Opinion in Oncology. 15(3). 197–203. 81 indexed citations
18.
Hartmann, Christian, Gaspar J. Kitange, Yanhong Wu, et al.. (2002). Transcript map of the 3.7-Mb D19S112-D19S246 candidate tumor suppressor region on the long arm of chromosome 19.. PubMed. 62(14). 4100–8. 54 indexed citations
19.
Hayashi, Kentarō, Naoki Kitagawa, Hideaki Takahata, et al.. (2002). Endovascular treatment for cervical carotid artery stenosis presenting with progressing stroke: three case reports. Surgical Neurology. 58(2). 148–154. 20 indexed citations
20.
Hayashi, Kentarō, Hideaki Takahata, Naoki Kitagawa, et al.. (2001). N-acetylcysteine inhibited nuclear factor-κB expression and the intimal hyperplasia in rat carotid arterial injury. Neurological Research. 23(7). 731–738. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026